Modern Chinese Medicine Group Co., Ltd.

Research Modern Chinese Medicine Group Co., Ltd. (1643.HK) on Bullrun: market cap HKD 262.80M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 262.80M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 145.17M-CNY 13.56M-CNY 17.73M16.2%n/aCNY 229.71MCNY 69.00KCNY 497.99M
FY2024CNY 214.07MCNY 9.67M-CNY 55.32M25.8%0.02CNY 229.67MCNY 135.00KCNY 484.23M
FY2023CNY 344.08MCNY 48.80MCNY 3.38M30.3%0.08CNY 286.27MCNY 72.00KCNY 472.89M
FY2022CNY 399.66MCNY 87.83MCNY 114.06M42.7%0.15CNY 282.26MCNY 393.00KCNY 422.93M
FY2021n/an/an/an/a0.14n/an/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 262.80Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

YearDividends/share
FY20220.02 CNY

About Modern Chinese Medicine Group Co., Ltd.

Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines in the People's Republic of China.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Modern Chinese Medicine Group Co., Ltd.'s market cap?

Modern Chinese Medicine Group Co., Ltd.'s market capitalization is HKD 262.80M.

What does Modern Chinese Medicine Group Co., Ltd. do?

Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines in the People's Republic of China. It provides vigour and vitality supplement, circulation enhancement pills, cardiotonic enhancement capsules, kidney invigoration pill, heart wellness capsules, menstrual discomfort relief, liver detox tablets, additional ingredient Huoxiang Zheng Qi pill, liver-dispersing and stomach regulating pills, and fever- removing and detoxification pills.